While Medtronic's shares have trailed the S&P 500 over the past year, Wall Street maintains a cautiously optimistic stance, buoyed by strong recent earnings and raised guidance.
ASML Holding NV has launched a massive new share repurchase program and reaffirmed strong sales guidance, as record AI-related equipment orders fuel optimism about the Dutch tech giant's central role in the semiconductor industry's future.
Tyson Foods reported mixed Q1 FY2026 results, with strong momentum in Prepared Foods and Chicken segments offset by significant challenges in Beef due to constrained cattle supplies. The company also unveiled a new segment reporting structure aimed at enhancing transparency for investors.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
Alliance Resource Partners (ARLP) posted a significant jump in fourth-quarter profit, driven by cost controls and investment gains, even as coal revenue softened. The partnership issued 2026 guidance pointing to robust contract coverage and a growing oil & gas royalty segment, while navigating challenges at a key Appalachian mine.
Amid market volatility driven by AI speculation, a seasoned investor makes the case for a dual-anchor strategy built on Apple's surging iPhone sales and Berkshire Hathaway's formidable $378 billion cash reserve.
Fourth-quarter earnings for S&P 500 companies are significantly outperforming expectations, led by robust growth in industrial and tech sectors, as investors await a busy week of corporate results and key economic data.
Alliance Resource Partners (ARLP) reported robust fourth-quarter earnings, driven by cost discipline and a resilient coal market. The company provided optimistic 2026 guidance, citing strengthening demand from data centers, industrial growth, and recent winter storms that underscored coal's critical role in grid reliability.
Palantir Technologies prepares to report Q4 2025 earnings after the bell, with Wall Street eyeing $1.33 billion in revenue and $0.23 EPS. The stock's recent 17.5% slump underscores investor anxiety over its premium valuation and the sustainability of its explosive commercial growth.
Despite a sharp sell-off in its shares, HubSpot reports a surge in new contract signings and projects an expanding free cash flow margin, signaling underlying operational strength even as investors remain wary.
Despite recent guidance revisions, Mobileye Global retains strong buy ratings from analysts who see significant upside potential, as the company positions 2026 for a strategic transition in the autonomous driving sector.
Following a price target adjustment by Leerink Partners, Kura Oncology (KURA) is drawing investor focus to its 2026 clinical milestones and commercial strategy for its newly launched AML drug, ziftomenib.
With shares up over 100% in a year, investors are weighing whether to buy AMD stock before its February 3rd earnings report, as the chipmaker capitalizes on the AI boom.
A revised analyst price target for Grupo Financiero Banorte (BMV:GFNORTE O) is refocusing investor attention on the Mexican banking giant, highlighting how evolving assessments of risk and growth potential can rapidly reshape a stock's narrative.
Giverny Capital's latest investor letter highlights Arista Networks as a standout performer, driven by strong earnings and strategic positioning in the high-speed networking sector crucial for AI and cloud expansion.
As Nvidia prepares to report its fiscal Q4 earnings on February 25th, investors are weighing whether to buy ahead of the event. While the AI chip leader's long-term story remains compelling, a look at its recent post-earnings stock performance reveals a pattern that favors a measured approach over trying to time the market.
Stifel Nicolaus lowered its price target on Altria Group (MO) by $4 to $68, citing higher-than-expected operating costs. Despite near-term headwinds, the firm reaffirmed its Buy rating, pointing to the tobacco giant's resilient dividend profile and long-term earnings guidance.
Bassett Furniture Industries (NASDAQ: BSET) has seen significant price swings in recent months, drawing investor scrutiny. With a current trading price well below its calculated intrinsic value and a bullish earnings forecast, analysts are debating whether this small-cap furniture maker presents a timely buying opportunity.
SoundHound AI's shares have retreated to their most affordable level in over a year, presenting a potential entry point for investors betting on the widespread adoption of its conversational AI. While revenue growth is robust, the path to profitability and consumer acceptance of AI agents remain critical hurdles.
